Inventor · disambiguated record
Marianne Stanford
Also filed as: STANFORD MARIANNE · STANFORD MARIANNE M · STANFORD MARIANNE MICHELLE
8 granted patents·13 pending applications·8 citations·filing 2006–2022
80Inventor score
Top patents by PatentIndex Score
21 records- 0183US11260116B2Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2017·Granted Mar 1, 2022·2 cites·22 claims
- 0282US10729766B2Method for improving the efficacy of a survivin vaccine in the treatment of cancerIMMUNOVACCINE TECHNOLOGIES INC·Filed 2018·Granted Aug 4, 2020·1 cites·28 claims
- 0379US10988500B2Lipid A mimics, methods of preparation, and uses thereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2019·Granted Apr 27, 2021·1 cites·22 claims
- 0476US11406705B2Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjectsIMMUNOVACCINE TECHNOLOGIES INC·Filed 2016·Granted Aug 9, 2022·2 cites·20 claims
- 0570US10022441B2Method for improving the efficacy of a survivin vaccine in the treatment of cancerIMMUNOVACCINE TECHNOLOGIES INC·Filed 2013·Granted Jul 17, 2018·1 cites·29 claims
- 0669US9987315B2Use of a combination of Myxoma virus and rapamycin for therapeutic treatmentUNIV WESTERN ONTARIO·Filed 2013·Granted Jun 5, 2018·0 cites·12 claims
- 0767US12042537B2Methods of using low dose volume B-cell epitope compositions for inducing an antibody immune response in human subjectsBIOVAXYS INC·Filed 2022·Granted Jul 23, 2024·0 cites·19 claims
- 0867US2018256656A1Use of a combination of myxoma virus and rapamycin for therapeutic treatmentUNIV WESTERN ONTARIO·Filed 2018·Application pending·0 cites
- 0966US10533033B2Lipid A mimics, methods of preparation, and uses thereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2015·Granted Jan 14, 2020·1 cites·35 claims
- 1064US2021052724A1Method for improving the efficacy of a survivin vaccine in the treatment of cancerIMMUNOVACCINE TECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 1164US2022143165A1Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2022·Application pending·0 cites
- 1256US2013171106A1Use of a combination of myxoma virus and rapamycin for therapeutic treatmentROBARTS RES INST·Filed 2012·Application pending·0 cites
- 1355US2009035276A1Use of a combination of myxoma virus and rapamycin for therapeutic treatmentROBARTS RES INST·Filed 2006·Application pending·0 cites
- 1453US2023355526A1Lipid compositions comprising polynucleotide antigensIMMUNOVACCINE TECHNOLOGIES INC·Filed 2021·Application pending·0 cites
- 1551US2022125903A1Methods for improving the efficacy of a survivin therapeutic in the treatment of tumorsIMMUNOVACCINE TECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 1650US2011195050A1Use of a combination of myxoma virus and rapamycin for therapeutic treatmentROBARTS RES INST·Filed 2010·Application pending·0 cites
- 1748US2023000769A1Oil-in-water emulsion formulations for delivery of active or therapeutic agentsIMMUNOVACCINE TECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 1848US2021147544A1Methods and compositions for targeted delivery of active agents and immunomodulatory agents to lymph nodesIMMUNOVACCINE TECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 1943US2020230057A1Pharmaceutical Compositions, Methods for Preparation using Lipid Vesicle Particles of Defined Size, and Uses ThereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2017·Application pending·0 cites
- 2043US2020353062A1Pharmaceutical compositions, methods for preparation comprising sizing of lipid vesicle particles, and uses thereofIMMUNOVACCINE TECHNOLOGIES INC·Filed 2017·Application pending·0 cites
- 2140US2018162913A1Methods for potentiating an immune response using depot-forming and non-depot-forming vaccinesIMMUNOVACCINE TECHNOLOGIES INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →